These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20176578)

  • 1. Stability of meropenem and doripenem solutions for administration by continuous infusion.
    Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM
    J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578
    [No Abstract]   [Full Text] [Related]  

  • 2. Stability of doripenem in vitro in representative infusion solutions and infusion bags.
    Psathas PA; Kuzmission A; Ikeda K; Yasuo S
    Clin Ther; 2008 Nov; 30(11):2075-87. PubMed ID: 19108795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem.
    Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D
    J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability of meropenem in normal saline solution after storage at room temperature.
    Jaruratanasirikul S; Sriwiriyajan S
    Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):627-9. PubMed ID: 15115140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of generic meropenem solutions for administration by continuous infusion at normal and elevated temperatures.
    Franceschi L; Cojutti P; Baraldo M; Pea F
    Ther Drug Monit; 2014 Oct; 36(5):674-6. PubMed ID: 24637698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbapenems in the USA: focus on doripenem.
    Lister PD
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):793-809. PubMed ID: 17914914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of intravenous infusion of doripenem.
    Redman R; File TM
    Clin Infect Dis; 2009 Aug; 49 Suppl 1():S28-35. PubMed ID: 19619019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenems: a potent class of antibiotics.
    Nicolau DP
    Expert Opin Pharmacother; 2008 Jan; 9(1):23-37. PubMed ID: 18076336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
    Horiuchi M; Kimura M; Tokumura M; Hasebe N; Arai T; Abe K
    Toxicology; 2006 May; 222(1-2):114-24. PubMed ID: 16549226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lucasti et al in the May 2008 issue of Clinical Therapeutics.
    Porath AD
    Clin Ther; 2008 Oct; 30(10):1934; author reply 1934-6. PubMed ID: 19014850
    [No Abstract]   [Full Text] [Related]  

  • 13. Stability of meropenem in a portable infusion device in a cold pouch.
    Grant EM; Zhong MK; Ambrose PG; Nicolau DP; Nightingale CH; Quintiliani R
    Am J Health Syst Pharm; 2000 May; 57(10):992-5. PubMed ID: 10832500
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacokinetics, safety, and tolerability of doripenem after 0.5-, 1-, and 4-hour infusions in healthy volunteers.
    Cirillo I; Vaccaro N; Turner K; Solanki B; Natarajan J; Redman R
    J Clin Pharmacol; 2009 Jul; 49(7):798-806. PubMed ID: 19553404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doripenem (Doribax)--a new parenteral carbapenem.
    Med Lett Drugs Ther; 2008 Jan; 50(1278):5-7. PubMed ID: 18219262
    [No Abstract]   [Full Text] [Related]  

  • 16. Cure of persistent, post-appendectomy Klebsiella pneumoniae septicaemia with continuous intravenous administration of meropenem.
    Falagas ME; Siempos II; Tsakoumis I
    Scand J Infect Dis; 2006; 38(9):807-10. PubMed ID: 16938737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penetration of doripenem into prostatic tissue following intravenous administration in prostatectomy patients.
    Yamada Y; Ikawa K; Nakamura K; Mitsui K; Narushima M; Hibi H; Ikeda K; Morikawa N; Honda N
    Int J Antimicrob Agents; 2010 May; 35(5):504-6. PubMed ID: 20188521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and degradation kinetics of meropenem in powder for injection and reconstituted sample.
    Mendez AS; Dalomo J; Steppe M; Schapoval EE
    J Pharm Biomed Anal; 2006 Jun; 41(4):1363-6. PubMed ID: 16533586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incompatibility of ciprofloxacin and meropenem injections.
    Chen LY; Chen J; Waters V; Boodhan S
    Am J Health Syst Pharm; 2013 Nov; 70(22):1966, 1970. PubMed ID: 24173004
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of in vivo nephrotoxicity in the rabbit by a pyrrolidinyl-thio Carbapenem CW-270031.
    Kim JM; Ha JR; Oh SW; Kim HG; Lee JM; Kim BO; Lee DG; Lee SH; Kim JG
    J Microbiol Biotechnol; 2008 Nov; 18(11):1768-72. PubMed ID: 19047819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.